Hot Products

Human Mesenchymal Stem Cells

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C8006L
Description
Mesenchymal stem cells are harvested and cultured from normal human bone marrow. Cell purity is far higher than cells from traditional Dexter cultures. Cells are tested for purity by flow cytometry and for their ability to differentiate into osteogenic, chondrogenic and adipogenic lineages. Cells are positive for CD105, CD166, CD29, and CD44. Cells test negative for CD14, CD34 and CD45. Media systems are available to support growth of hMSCs and their differentiation into adipogenic, chondrogenic, and osteogenic lineages.
Species
Human
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Human Mesenchymal Stem Cells (hMSCs) represent multipotent adult stem cells that can be found throughout different tissues and organs such as bone marrow, fat tissue, umbilical cord, placenta, and muscle. With the right in vitro or in vivo induction conditions hMSCs can transform into diverse cell types including osteoblasts, chondrocytes, adipocytes, neurons, hepatocytes and cardiomyocytes. The ability of hMSCs to differentiate into multiple cell types positions them as valuable tools for tissue repair and regenerative medicine.

hMSCs demonstrate immunomodulatory functions that enable them to suppress inflammatory responses and control immune cell activity. The distinctive properties of hMSCs enable them to provide special benefits in autoimmune disease treatment and transplant rejection reduction. hMSCs show standard surface markers CD73, CD90, and CD105 but do not display hematopoietic markers CD45 and CD34. The low immunogenicity of hMSCs helps prevent immune system rejection during allogeneic transplantation procedures. Furthermore, hMSCs demonstrate a significant ability to multiply quickly which enables their rapid growth in laboratory conditions to produce a sufficient quantity of cells for medical treatments. Therefore, hMSCs serve as essential cell lines for use in cell therapy treatments.

The properties of mesenchymal stem cells.Fig. 1. The properties of MSCs (Ma S, Xie N, et al., 2014).

Effects of MXene NPs on Calcium Deposition and Mineralization of hMSCs

Bone tissue damage remains a significant challenge in dental and orthopedic therapy due to limitations of current treatments. Lee et al. developed a bioink incorporating MXene nanoparticles into GelMA and HAMA to explore its potential in bone tissue engineering. The bioink was 3D printed with encapsulated human mesenchymal stem cells (hMSCs) to evaluate its cytocompatibility and osteogenic properties.

To explore whether MXene nanoparticles (NPs) can induce osteogenic differentiation of human mesenchymal stem cells (hMSCs), they conducted ARS and von Kossa staining to measure calcium deposition. Calcium deposition is a key marker of late-stage osteogenesis. ARS staining showed no significant calcium deposition at 7 days for cells treated with up to 40 μg/mL MXene NPs compared to controls. However, significant increases were observed at 14 and 21 days, with 20 μg/mL MXene NPs yielding the highest deposition (Fig. 1a and b). Von Kossa staining also revealed increased mineralized bone nodules at 21 and 28 days in hMSCs treated with MXene NPs, compared to controls (Fig. 1c and d). Previous studies suggest that MXene NPs below 20 μg/mL can upregulate early and late osteogenic genes, promoting differentiation. Based on cytotoxicity and osteogenesis assessments, we determined the optimal MXene NP concentration to be 20 μg/mL.

Osteogenic differentiation of human mesenchymal stem cells treated with MXene NPs.Fig. 1. Osteogenic differentiation of hMSCs treated with MXene NPs (Lee S H, Kang M S, et al., 2023).

Higher Viscosity of Extracellular Fluid Enhanced Cell Spreading

Human mesenchymal stem cells (hMSCs) could serve as a treatment for osteoporosis but their osteogenic differentiation requires further improvement. While viscosity affects cellular functions through biomechanical signals the specific influence of viscosity on hMSC osteogenesis remains unknown. Chen's team studied the biomechanical behavior of hMSCs by growing them in a high-viscosity medium to examine changes in cellular spreading and intracellular tension.

They studied how ECF viscosity affects hMSCs' biomechanical properties and differentiation by changing the culture medium's viscosity using different methylcellulose (MC) concentrations (0%, 0.2%, 0.4%, 0.8%). Viscosity increased with more MC, with values at 0%, 0.2%, 0.4%, and 0.8% being 0.98 ± 0.04, 8.44 ± 1.94, 21.83 ± 3.21, and 68.14 ± 1.59 cP, respectively (Fig. 2A and B). Viscosities at 0.4% and 0.8% MC are similar to hMSCs' natural environments like bone marrow. They tested medium viscosity effects on biomechanical properties, including cell spreading, actin polymerization, and focal adhesion. hMSCs were cultured on glass and observed with IRM, showing rapid spreading in high-viscosity medium (Fig. 2C), which also increased cell spread (Fig. 2D and E). They further analyzed viscosity impact over six hours, showing cell spread peaked at 60 minutes and fluctuated due to migration.

Higher viscosity of extracellular fluid significantly increased the spreading area of hMSCs.Fig. 2. Higher viscosity of extracellular fluid significantly increased the spreading area of human mesenchymal stem cells (hMSCs) (Chen YQ, Wu MC, et al., 2024).

Ask a Question

Write your own review

For research use only. Not for any other purpose.